Pomegranate Juice (Ellagitannins)

Lowers blood pressure by a different route than beets, and the two plausibly stack.

Mechanisms, studies and evidence grades for each point above.

What it is

Pomegranate's characteristic compounds are ellagitannins: punicalagin, punicalin, pedunculagin and gallagic acid. These hydrolysable tannins are concentrated in the peel and present in smaller amounts in the arils and juice. They are large molecules and barely absorbed intact. Some of their effects happen in the gut itself (the blood-sugar effect below), and most of the rest depend on gut bacteria turning them into smaller, absorbable urolithins.

Lowers blood pressure

The main route is angiotensin-converting enzyme (ACE) inhibition, the same target as the “-pril” drugs (lisinopril, ramipril). ACE turns angiotensin I into angiotensin II, which tightens blood vessels; block it and vessel tone relaxes. An early human study found serum ACE activity fell 36% after pomegranate juice.¹ That study was small and industry-funded, but the active compounds have since been isolated by an independent group: pedunculagin, punicalin and gallagic acid inhibit ACE at IC₅₀ values of about 0.9–1.8 µM, apparently by binding the enzyme's catalytic zinc.² (Strong for the biochemistry; Moderate for the effect in people)

A second route adds to the first: punicalagin activates endothelial nitric oxide synthase (eNOS), so the vessel lining makes more nitric oxide. Beet juice works differently. It bypasses eNOS by supplying nitrate that oral bacteria turn into nitrite and then NO, which is why it still works when the endothelium is struggling. Pomegranate works through eNOS, so it needs reasonably healthy endothelium to act on. (Animal and cell studies for the eNOS route)

In trials the effect is real but modest. Two meta-analyses (8 and 14 RCTs) agree on about a 5 mmHg fall in systolic pressure.^3,4 They share a senior author, so they are not fully independent. The larger one adds two findings that matter for how to use it:⁴

• The effect was lost after about two months of daily intake. If that holds, pomegranate is something to use for a stretch, not a permanent daily fix.
• More was not better. Doses of 300 mL/day or less gave the largest systolic drop; larger doses did less.

Both findings rest on fewer, smaller long-duration and high-dose trials, so either could be noise. (Contested)

Blunts the blood-sugar spike from starchy food

Two crossover trials at the University of Leeds (16 people each) gave pomegranate juice with white bread. Compared with a drink carrying the same sugar, the juice cut the glucose spike by 33%. A pomegranate extract capsule did nothing, and neither did the juice's fruit acids on their own. In the lab, punicalagin blocked the starch-digesting enzyme α-amylase about as well as the diabetes drug acarbose.⁵ This happens in the gut, so it doesn't depend on urolithins, and the work had no industry funding.

The longer-term effect is small. Across 32 RCTs, fasting glucose fell 2.2 mg/dL and HbA1c 0.22%.⁶ The useful part is the meal effect: drink it with a starchy meal, not on its own. (Moderate)

Protects LDL from oxidation

In healthy men, two weeks of pomegranate juice made LDL less prone to aggregate and raised paraoxonase, an HDL-bound enzyme that protects lipids from oxidation, by 20%. In atherosclerosis-prone mice the same juice cut macrophage oxidation of LDL by up to 90% and shrank arterial lesions by 44%.⁷ In 10 patients with carotid stenosis, a year of juice lowered LDL oxidation markers and reduced carotid wall thickness, while it grew in untreated controls.⁸ This fits the oxidation argument in Linoleic Acid & Metabolic Disease: LDL does its damage once it is oxidised, and these polyphenols act on that step.

The wider anti-inflammatory signal is small but consistent. A meta-analysis of 33 RCTs found lower CRP, IL-6, TNF-α and the lipid-oxidation marker MDA, and higher total antioxidant capacity; CRP fell about 0.5 mg/L.⁹ Pomegranate juice also ranks first among common drinks on lab antioxidant scores,¹⁰ though those test-tube scores say little about what happens in the body. It does not lower LDL itself: across 37 RCTs only HDL moved, up 2.5 mg/dL.¹¹

The LDL-oxidation studies are small, come from one research programme, and were funded by POM Wonderful (see below). No trial has measured heart attacks or strokes. (Early)

May help hold memory steady with age

A 4-week UCLA pilot in 28 older adults with mild memory complaints improved one verbal-memory test.¹² The follow-up 12-month RCT (261 people, 8 oz/day) found a difference on one visual-learning score: it held steady on juice and declined on placebo. The other memory measures didn't differ.¹³ So the fair reading is that it may slow one kind of age-related memory decline, not that it improves memory. (Early)

Why it works for some people and not others

In the gut, ellagitannins break down to ellagic acid, which bacteria then convert into urolithins. Human enzymes can't do this step. People fall into three urolithin metabotypes: A makes urolithin A only; B also makes urolithin B and isourolithin A; and 0 makes essentially none, because the right bacteria (Gordonibacter and Enterocloster species among them) are missing. These three types show up consistently across trials regardless of food source, age or health.¹⁴ In a randomized trial in overweight adults, metabotype explained much of who saw their cardiovascular risk markers improve on pomegranate.¹⁵ Estimates of how many people are non-producers range from about 10% to over 40% depending on population and method. (Strong that metabotypes exist; Contested on the proportions)

Beet juice has the same feature: it depends on oral bacteria to make nitrite. In both cases the active molecule is made by something living in you, so the trial average may not apply to you. It is worth testing on yourself.

Smaller findings

• Cortisol: in a 4-week crossover trial, 28 overweight adults drinking 500 mL/day had a lower cortisol-to-cortisone ratio in urine and saliva, which fits reduced activity of 11βHSD1, the enzyme that regenerates cortisol. Urinary cortisol itself didn't fall significantly.¹⁶ (Early)
• Liver enzymes: a meta-analysis of 9 RCTs found lower GGT; AST and ALT fell only in obese and metabolic-disorder subgroups and in trials longer than 8 weeks, with signs of publication bias.¹⁷ The best single trial used peel-extract capsules plus a calorie-restricted diet: liver enzymes improved, fatty-liver grade didn't.¹⁸ (Weak, and mostly peel extract rather than juice)
• Aromatase: urolithin B inhibits aromatase, the enzyme that makes estrogen from testosterone, in enzyme assays and breast-cancer cells.¹⁹ No human studies. It also requires a metabotype that makes urolithin B.
• Sleep: in an open-label trial in 58 people on methadone or buprenorphine, 250 mL/day for 120 days raised salivary melatonin, and sleep quality improved in the methadone group.²⁰ (Early)

Who funded the research

POM Wonderful and its owners funded a large share of the clinical literature, reportedly over $35 million across a hundred-plus studies, including Michael Aviram's foundational ACE and LDL-oxidation work. In 2010 the FTC charged the company with deceptive advertising over heart-disease, prostate-cancer and erectile-dysfunction claims, and the D.C. Circuit upheld the ruling in 2015. A widely promoted “30% plaque reduction” came, the FTC found, from a single company-funded pilot of 19 people.

The biochemistry isn't affected: ACE inhibition by these compounds has been confirmed by independent groups,² and the blood-sugar trials had no industry funding.⁵ The funded clinical results deserve a discount, which is why this page weights mechanism above the trials.

Safety

• Sugar: about 30 g of sugar and 130 kcal per cup (240 mL), a poor trade for someone whose real problem is insulin resistance. Whole arils carry the same compounds with the fibre intact.
• ACE inhibitors and ARBs: pomegranate on top of these drugs is the same intervention twice and could add to the blood-pressure drop. Raise it with your doctor.
• Warfarin: there are scattered case reports of raised INR.
• CYP3A4: pomegranate inhibits this drug-metabolising enzyme in the test tube, but human studies have mostly not found a clinically meaningful effect; it is much weaker than grapefruit. If you're on a narrow-margin drug, don't rely on that reassurance.
• Peel extracts concentrate the tannins and can upset the gut at higher doses.

How to take it

• Form: whole arils beat juice: fibre, slower sugar, same ellagitannins. Juice is what the trials used, not necessarily what makes sense. If using juice, unsweetened and not from concentrate.
• Dose: 150–300 mL (about ⅔ to 1¼ cups) of juice. The blood-pressure signal was strongest at 300 mL/day or less, so more isn't better.
• Timing: with a starchy meal, to blunt the sugar spike.
• Cycle it: since the blood-pressure effect seems to fade after about two months, use it situationally or in stretches rather than every day. No trial has tested a cycling schedule.
• Pair with beets: pomegranate and beet juice work on different sides of the same system, so think of them as complementary.
• Don't expect it to carry the load: weight loss, aerobic training and the sodium/potassium balance do more for the same endpoint. See the blood-pressure stack. The juice-sugar trade-off is worked through in more depth on the orange juice page.

References